Precision BioSciences, Inc. Common Stock (DTIL) is a publicly traded Healthcare sector company. As of May 21, 2026, DTIL trades at $7.18 with a market cap of $179.58M and a P/E ratio of -3.32. DTIL moved +3.77% today. Year to date, DTIL is +75.98%; over the trailing twelve months it is +47.13%. Its 52-week range spans $3.53 to $9.81. Analyst consensus is strong buy with an average price target of $36.33. Rallies surfaces DTIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Precision BioSciences, Inc. Common Stock (DTIL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DTIL moved +3.77% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $7.18 |
| Market Cap | $179.58M |
| P/E Ratio | -3.32 |
| EPS | $-2.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.81 |
| 52-Week Low | $3.53 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $45.07M |
| Net Income | $-43.60M |
| Gross Margin | 0.00% |
3 analysts cover DTIL: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.33.